Li S, Gu HQ, Feng B, Li H, et al. Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4.5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial. Lancet Neurol 2024 Nov 28:S1474-4422(24)00436.
PMID: 39617030